Blue MAP Pharmachem Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Blue MAP Pharmachem Pharmaceutical Export Portfolio Dataset — 2 Products, $1.2M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Blue MAP Pharmachem — Pharmaceutical Exporter Profile (2026) | 2 Products, $1.2M Trade | TransData Nexus

Blue MAP Pharmachem

Indian Pharmaceutical Exporter · Antimalarial & Antiparasitic Specialist · $1.2M Total Trade · DGFT Verified

Blue MAP Pharmachem is an Indian pharmaceutical exporter with a total trade value of $1.2M across 2 products in 2 therapeutic categories. Based on 43 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Artesunate ($1.1M), Chondroitin ($104.7K), .

Blue MAP Pharmachem — Export Portfolio & Destination Treemap

Blue MAP Pharmachem pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Blue MAP Pharmachem? — Company Overview & Market Position

Blue MAP Pharmachem is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2006, the company is headquartered at 5th Floor, 513/514, Agarwal B2B Centre, Kanchpada Road, Off Link Road, Malad West, Mumbai, Maharashtra, 400064, India. The business operates as a sole proprietorship under the legal name Vikram Ashok Panjwani. It is registered with the Directorate General of Foreign Trade (DGFT) under the Importer Exporter Code (IEC) number RA000709. The company holds a Goods and Services Tax (GST) registration number 27APRPP3311H1ZQ, indicating its active status as of July 1, 2017. While specific revenue figures are not publicly disclosed, Blue MAP Pharmachem has demonstrated a consistent export performance, with a total export value of $1.2 million USD across 43 shipments from 2022 to 2026. The company's product portfolio is concentrated, with its top two products—Artesunate and Chondroitin—accounting for 100% of its exports. The workforce comprises a dedicated team, though exact employee numbers are not specified in the available sources.

What Does Blue MAP Pharmachem Export? — Product Portfolio Analysis

Top Products by Export Value

1Artesunate$1.1M

Product Portfolio — Top 2 by Export Value

Blue MAP Pharmachem exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Artesunate	Antimalarial & Antiparasitic	$1.1M	40	0.7%	14
2	Chondroitin	Nutritional Supplements	$104.7K	3	2.1%	10

Blue MAP Pharmachem exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $1.2M. The top category is Antimalarial & Antiparasitic (91.4% of portfolio), followed by Nutritional Supplements (8.6%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Blue MAP Pharmachem — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Blue MAP Pharmachem's manufacturing operations are based in India, with facilities located in Mumbai, Maharashtra. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding manufacturing capacities and certifications are not publicly available. The company's focus on finished formulations indicates a commitment to quality and compliance with international standards, catering to various therapeutic categories.

3Key Leadership

The available sources do not provide detailed information about the key leadership team at Blue MAP Pharmachem. The company's legal name is Vikram Ashok Panjwani, suggesting that Mr. Panjwani may hold a significant leadership role. However, without explicit confirmation, it is not possible to accurately identify the CEO, CFO, or other key executives.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Blue MAP Pharmachem Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Blue MAP Pharmachem's export activities primarily focus on markets in Africa, with notable shipments to Ghana. The company's product portfolio includes Artesunate and Chondroitin, both of which are used in the treatment of malaria and related conditions. While specific regulatory approvals for the U.S., EU, UK, Australia, and Japan are not detailed in the available sources, the company's export activities suggest compliance with international standards. The absence of explicit regulatory filings or approvals in these regions indicates that Blue MAP Pharmachem may not currently have market access in these countries.

2Emerging Markets

Blue MAP Pharmachem has demonstrated a presence in emerging markets, particularly in Africa. The company's export data indicates shipments to Ghana, highlighting its engagement in the African pharmaceutical market. While specific information regarding WHO prequalification or other certifications enabling access to these markets is not available, the company's export activities suggest a focus on meeting international standards for pharmaceutical products.

3Geographic Strategy

Blue MAP Pharmachem — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Blue MAP Pharmachem's interactions with the U.S. Food and Drug Administration (FDA) is not available in the provided sources. The company's export data does not indicate shipments to the United States, suggesting that it may not currently have FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or a history of FDA inspections. Without explicit confirmation, it is not possible to assess the company's FDA status accurately.

2WHO & EU GMP

The available sources do not provide information regarding Blue MAP Pharmachem's compliance with World Health Organization (WHO) prequalification or European Union Good Manufacturing Practice (EU GMP) certifications. The company's export activities, particularly in Africa, suggest a focus on meeting international standards; however, without explicit confirmation, it is not possible to assess the company's adherence to WHO or EU GMP standards.

3CDSCO & Indian Regulatory

Blue MAP Pharmachem — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Blue MAP Pharmachem operates in the competitive pharmaceutical export market, focusing on finished formulations like Artesunate and Chondroitin. While specific competitors in overlapping categories are not detailed in the available sources, the company's export data indicates a presence in markets such as Ghana. The absence of explicit information regarding market share comparisons and head-to-head analyses suggests that Blue MAP Pharmachem may face competition from both local and international pharmaceutical companies in its target markets.

2Key Differentiators

Blue MAP Pharmachem's key differentiators include its specialization in finished pharmaceutical formulations and a concentrated product portfolio. The company's focus on products like Artesunate and Chondroitin positions it in the niche market of antimalarial and nutritional supplements. While specific competitive advantages are not detailed in the available sources, the company's export activities suggest a commitment to quality and compliance with international standards.

3Strategic Position

Blue MAP Pharmachem's current strategic direction appears focused on exporting finished pharmaceutical formulations, with a concentrated product portfolio. The company's export data indicates a presence in markets such as Ghana, suggesting a strategy targeting specific regions. The absence of explicit information regarding future outlooks, such as plans to expand into generics, specialty drugs, biosimilars, or contract development and manufacturing organizations (CDMO), indicates that the company's strategic direction may be evolving.

Buyer Due Diligence Brief — Evaluating Blue MAP Pharmachem as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Blue MAP Pharmachem's export data indicates a consistent track record, with a total export value of $1.2 million USD across 43 shipments from 2022 to 2026. The company's product portfolio is concentrated, with its top two products—Artesunate and Chondroitin—accounting for 100% of its exports. The company's export activities suggest reliability in fulfilling orders; however, without explicit information regarding supplier relationships, it is not possible to assess the company's overall reliability indicators comprehensively.

2Certifications to Verify

Importers considering partnerships with Blue MAP Pharmachem should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the company's registration with the U.S. Food and Drug Administration (FDA) to ensure compliance with U.S. regulations. Verification can be done through the FDA's official website or by contacting the company directly.

WHO-GMP Certification: Verify adherence to World Health Organization Good Manufacturing Practice (WHO-GMP) standards to ensure product quality and safety. This can be confirmed through the WHO's official website or by requesting certification details from the company.

Frequently Asked Questions — Blue MAP Pharmachem

How many pharmaceutical products does Blue MAP Pharmachem export from India?

Blue MAP Pharmachem exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Artesunate ($1.1M), Chondroitin ($104.7K). Total export value is $1.2M.

What is Blue MAP Pharmachem's total pharmaceutical export value?

Blue MAP Pharmachem's total pharmaceutical export value is $1.2M, based on 43 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Blue MAP Pharmachem cover?

Blue MAP Pharmachem exports across 2 therapeutic categories. The largest are Antimalarial & Antiparasitic (91.4%, 1 products), Nutritional Supplements (8.6%, 1 products).

Get Full Blue MAP Pharmachem Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.